ANI Pharmaceuticals Inc

NASDAQ:ANIP   4:00:00 PM EDT
37.31
-0.69 (-1.82%)
4:05:10 PM EDT: $37.31 0.00 (0.00%)
Other Pre-Announcement

Ani Pharmaceuticals Reports Q3 2022 Financial Results

Published: 11/09/2022 12:24 GMT
ANI Pharmaceuticals Inc (ANIP) - Ani Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues.
Q3 Adjusted Non-GAAP Earnings per Share $0.64.
Q3 Revenue $83.8 Million Versus $52.1 Million.
Q3 GAAP Loss per Share $0.55.
Reiterates FY 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million.
Q3 Earnings per Share View $0.55, Revenue View $78.2 Million -- Refinitiv Ibes Data (analyst estimates).
Reiterates FY 2022 Adjusted Earnings per Share, Adjusted EBITDA Guidance.